Owns and operates the New York Knicks (NBA) and New York Rangers (NHL). Manages development league teams, including the Hartford Wolf Pack and Westchester Knicks. Now — the numbers.
The biggest line carries real weight, but it doesn’t decide everything on its own.
This is an established company with proven profits.
The market pays 1,216.6× for every dollar this company earns in a year — a price that already assumes things go well.
Against companies in its own sector, it looks cheaper than 18% of them.
Analysts' average target sits 27% above today's price.
Executives buying with their own money is usually read as confidence in the company’s future.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Clearly below the class average.
A solid grade overall — yet the debt outweighs the cash. The strength here comes from earnings power.
Clearly below the class average.
Sales are growing strongly for its sector.
The stock has been running stronger than the market lately.
Valuation: The stock trades at a price that looks expensive next to its earnings; that can cap future returns.
Business Quality: Profit power and business quality trail similar companies in the sector.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
Over the last 4 years, sales grew about 9% a year on average.
Over the last 12 months, company executives reported 42 buys and 15 sells. Management buying with its own money is usually read as a good sign.
The company’s market value is 1217 times its annual profit. Even a small disappointment could hit the price hard.
Today’s price already includes part of tomorrow’s optimism. Report-card grade: 18/100.
Measured against its sector, the quality of the business sits below the class average. Report-card grade: 45/100.
On our five-subject report card, MSGS sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: MSGS is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.
Analysts’ average target sits above today’s price, yet the valuation grade (18/100) says the stock isn’t cheap.